目的 探讨18F-FDG PET/CT显像结合高分辨率CT(high resolution CT,HRCT)对孤立性肺结节(solitary pulmonary nodule,SPN)的诊断价值。方法 回顾性分析124例SPN患者的18F-FDG PET/CT检查资料,其中76例加做HRCT扫描,所有病例经病理或临床随访证实。18F-FDG PET/CT通过目测法和半定量法判断病灶的代谢情况,结合CT或HRCT病灶的形态学特征判断良、恶性。结果 48例仅行18F-FDG PET/CT检查的SPN患者,正确诊断32例为恶性,8例为良性,假阳性与假阴性各4例。76例加做HRCT的患者,正确诊断62例恶性与8例良性,假阳性与假阴性分别为2例和4例。18F-FDG PET/CT 结合HRCT与单纯18F-FDG PET/CT诊断SPN的灵敏度、特异性及准确率分别为94%、80%、90%与89%、67%、83%。结论 18F-FDG PET/CT协同HRCT可提高对SPN性质判断的灵敏度、特异性及准确率。
Abstract
Objective To investigate the diagnostic value of 18F-FDG position emission tomography/computed tomography (PET-CT) combined with high-resolution CT(HRCT) for differentiating solitary pulmonary nodules(SPNs).Methods The clinical data on 124 patients with SPNs was retrospectively analyzed. All these patients underwent preoperative 18F-FDG PET/CT,and 76 of them were also subjected to HRCT. Each of these cases was confirmed pathologically or by clinical follow-up.Differential diagnosis of SPNs was made using morphological features in CT/HRCT, visually detectable metabolism and semi-quantitative method.Results Of the 48 patients examined with 18F-FDG PET/CT alone, 32 malignant SPNs and 8 benign ones were diagnosed correctly, but there were 4 false positive ones and 4 false negative ones. Among the 76 cases examined with 18F-FDG PET/CT plus HRCT, 62 malignant and 8 benign SPNs were diagnosed correctly,with 2 false positive and 4 false negative ones. The sensitivity ,specificity and accuracy of 18F-FDG PET/CT combined with HRCT were higher than those of PET/CT alone(94%,80% and 90% vs 89%,67% and 83%).Conclusions 18F-FDG PET/CT combined with HRCT can improve the sensitivity ,specificity and accuracy in differentiating SPN.
关键词
孤立性肺结节 /
体层摄影术 /
发射型计算机 /
X线摄影术 /
发射型计算机 /
脱氧葡萄糖
Key words
solitary pulmonary nodule /
tomogyaphy /
emission-comuted /
tomogyaphy /
x-ray computed /
deoxyglucose
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Imdahl A,Jenkner S,Brink I,et al.Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions[J].Eur J Cardiothorac Surg,2001,20(2):324-329.
[2] Bunyaviroch T, Coleman R E. PET evaluation of lung cancer[J].J Nucl Medi, 2006, 47(3): 451-469.
[3] Aquino S L, Halpem E F, Kuester L B , et al. FDG-PET and CT features of non-small cell lung cancer based on tumor type[J]. Int J Mol Med,2007,19(3):495-499.
[4] Boellaard R. Standards for PET image acquisition and quantitative data analysis[J]. J Nucl Med 2009,50 Suppl 1:11S-20S.
[5] Ober van Gómez López, Ana María García Vicente1, Antonio Francisco Honguero Martínez, et al. 18F-FDG-PET/CT in the assessment of pulmonary solitary nodules:comparison of different analysis methods and risk variables in the prediction of malignancy[J]. Transl Lung Cancer Res, 2015,4(3):228-235
[6] Aquino S L, Halpem E F, Kuester L B , et al. FDG-PET and CT features of non-small cell lung cancer based on tumor type[J].Int J Mol Med,2007,19(3):495-499.
[7] Mylene T Truong, Jane P Ko, Santiago E Rossi, et al. Update in the evaluation of the solitary pulmonary nodule[J]. Radio Graphics, 2014, 34(6):1658-1679.
[8] Lee H Y, Lee K S. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications[J]. J Thorac Imaging, 2011,26(2):106-18.
[9] Duilio D, Mirko B, Luca B, et al. Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients[J]. J Thorac Dis, 2017,9(8):2551-2559.
PDF(5930 KB)
